Ideas
Bob Elliott
CEO & CIO, Unlimited; ex-Investment Committee, Bridgewater
6:38
Avoid AI stocks; earnings expectations unrealistic.
AI capex of $5 trillion over five years requires implausible trillions in revenue to generate reasonable return. Earnings expectations for the next three quarters imply 31% annualized growth, the highest in 50 years, while data center growth is already slowing. Long-only investors should rebalance away from the AI mania rather than lean in.
Memory chip cycle strongest ever; buy.
Memory companies historically cyclical but now over 50% of Micron's revenue comes from long-term supply agreements locking in volume and pricing for 3-5 years with high gross margins. This structural shift warrants higher multiples than the current 5-6x forward earnings.
Buy high-yield for 7% yield, low vol.
High-yield credit offers a 7% yield with about one-third the volatility of equities and is well positioned in the AI supply chain (the picks and shovels that build data centers). Attractive alternative to equities.
Rotate into non-tech equities.
AI productivity will lift the broader economy. When non-tech parts of the market sell off, it creates opportunity; a rising tide will lift all ships. Growth momentum and the rotation trade support the rest of the market, not just tech.
Buy EM for cheap AI exposure.
Emerging markets and parts of China provide a cheaper way to get AI tech exposure. Valuations are more favorable than US tech, offering an interesting play at a discount.
Steepen yield curve; short long bonds.
Fed rate hikes, persistent inflation, and massive supply from AI hyperscaler debt and sovereign issuance will push long-end Treasury yields substantially higher. Investors should steepen the curve: favor belly of the curve (intermediate maturities) and avoid long bonds.
Steepen yield curve; short long bonds.
Fed rate hikes, persistent inflation, and massive supply from AI hyperscaler debt and sovereign issuance will push long-end Treasury yields substantially higher. Investors should steepen the curve: favor belly of the curve (intermediate maturities) and avoid long bonds.
Biotech wins from M&A and AI.
Biotech benefits from strong M&A activity and the adoption of AI to accelerate drug discovery. It offers a dual play on the M&A theme and the AI theme.
Buy Delta on strong air travel.
Airline demand is strong with robust pricing power and little passenger pushback. Industry capacity discipline keeps supply tight. Delta is a top pick with unique revenue and margin opportunities, poised for a positive earnings report.
Buy semi equipment and NVIDIA.
AI capex spending flows to semiconductor equipment suppliers and to NVIDIA. These picks-and-shovels names benefit from secular build-out and remain attractive long-term holdings.
This Bloomberg Markets video, published July 09, 2026,
features Bob Elliott, Mandeep Singh, David Lebovitz, Greg Peters, Michelle Weaver, Savanthi Syth, Matt Stucky
discussing QQQ, 000660.KS, MU, 005930.KS, HYG, IWM, RSP, EEM, TLT, IEF, IBB, DAL, SOXX, NVDA.
10 trade ideas extracted by AI with direction and confidence scoring.
Speakers:
Bob Elliott,
Mandeep Singh,
David Lebovitz,
Greg Peters,
Michelle Weaver,
Savanthi Syth,
Matt Stucky
· Tickers:
QQQ,
000660.KS,
MU,
005930.KS,
HYG,
IWM,
RSP,
EEM,
TLT,
IEF,
IBB,
DAL,
SOXX,
NVDA